Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

INTRODUCTION: Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimers Dement (Amst)
Asıl Yazarlar: Janssens, Jana, Vermeiren, Yannick, Fransen, Erik, Aerts, Tony, Van Dam, Debby, Engelborghs, Sebastiaan, De Deyn, Peter P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2018
Konular:
Blood-Based Biomarkers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://ncbi.nlm.nih.gov/pubmed/29552632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.01.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller